SCHEMBL7598536

SCHEMBL7598536

C=CCN1CC[N]C(C(C=C)N2CCCNCC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7703025 0.69 HTR3A (0.30)
SCHEMBL8757759 0.65 CXCR4 (0.50)
SCHEMBL64922 0.65 CXCR4 (0.50)
SCHEMBL360262 0.61 DRD3 (0.33)
SCHEMBL169698 0.61
SCHEMBL169700 0.61
SCHEMBL3804161 0.60 SIGMAR1 (0.30)
SCHEMBL2078295 0.60
SCHEMBL8581174 0.59 CXCR4 (0.40)
Hydrochloric Acid SCHEMBL3293047 0.59 SMN1; SMN2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1252153-A1 SUBSTITUTED PIPERIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF Boehringer Ingelheim Pharma KG (DE) 2002-10-30 EP claimed
WO-2001049676-A1 SUBSTITUTED PIPERIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-07-12 WO claimed